Cas 873776-28-4,1-(2-bromobutanoyl)-3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazole

873776-28-4

Post Buying Request

Basic information

Product Name: 1-(2-bromobutanoyl)-3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazole
Synonyms: 1-(2-bromobutanoyl)-3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazole
CAS NO:873776-28-4
Molecular Formula:
Molecular Weight: 421.284
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(2-bromobutanoyl)-3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazole(CAS DataBase Reference)
NIST Chemistry Reference: 1-(2-bromobutanoyl)-3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazole(873776-28-4)
EPA Substance Registry System: 1-(2-bromobutanoyl)-3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazole(873776-28-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 873776-28-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

873776-28-4 Suppliers

Recommended suppliers

873776-28-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 873776-28-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,7,7 and 6 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 873776-28:
(8*8)+(7*7)+(6*3)+(5*7)+(4*7)+(3*6)+(2*2)+(1*8)=224
224 % 10 = 4
So 873776-28-4 is a valid CAS Registry Number.

873776-28-4Upstream product

22118-12-3 2-bromobutanoyl chloride

873776-28-4Downstream Products

873776-28-4Relevant academic research and scientific papers

MITOTIC KINESIN INHIBITORS

-

Page/Page column 43-44, (2008/06/13)

The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 873776-28-4